
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Primary mediastinal large B-cell lymphoma differential diagnosis
Introduction
Overview
Overview
Primary mediastinal large B-cell lymphoma must be differentiated from other diseases that cause swollen face, superior vena cava syndrome, and fever, night sweats and weight loss such as hodgkin’s lymphoma, thymoma, and other non hodgkin’s lymphomas.
Differentiating [Disease name] from other Diseases
Differentiating [Disease name] from other Diseases
- Primary mediastinal large B-cell lymphoma must be differentiated from other diseases that cause swollen face, superior vena cava syndrome, and fever, night sweats and weight loss such as hodgkin’s lymphoma, thymoma, and other non hodgkin’s lymphomas.
- The differentiation is determined on the basis of biopsy findings and immunophenotype, which are as follows:
- Thymoma
- Thymic epithelial cells stain for epithelial markers such as keratin and epithelial membrane antigen.[1]
- Hodgkin’s lymphoma[2]
- Thymic carcinoma
- Acute myeloid Leukemia
- Diffuse large B-cell lymphoma
- Involvement of bone marrow or distant lymph nodes is indicative of systemic DLBCL with secondary mediastinal involvement.
- Mediastinal germ cell tumor[5]
- Germ cell tumor markers such as beta-human chorionic gonadotropin [hCG] and alpha fetoprotein are positive.
References
References
- β Kodama T, Watanabe S, Sato Y, Shimosato Y, Miyazawa N (January 1986). “An immunohistochemical study of thymic epithelial tumors. I. Epithelial component”. Am. J. Surg. Pathol. 10 (1): 26β33. PMIDΒ 2420219.
- β von Wasielewski R, Mengel M, Fischer R, Hansmann ML, HΓΌbner K, Franklin J, Tesch H, Paulus U, Werner M, Diehl V, Georgii A (October 1997). “Classical Hodgkin’s disease. Clinical impact of the immunophenotype”. Am. J. Pathol. 151 (4): 1123β30. PMCΒ 1858022. PMIDΒ 9327746.
- β Suster S, Rosai J (February 1991). “Thymic carcinoma. A clinicopathologic study of 60 cases”. Cancer. 67 (4): 1025β32. PMIDΒ 1991250.
- β Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (May 2016). “The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia”. Blood. 127 (20): 2391β405. doi:10.1182/blood-2016-03-643544. PMIDΒ 27069254.
- β Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Sokal M, Gray E, McKeever P, Hale J, Bailey S, Oakhill A (November 2000). “The United Kingdom Children’s Cancer Study Group’s second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity”. J. Clin. Oncol. 18 (22): 3809β18. doi:10.1200/JCO.2000.18.22.3809. PMIDΒ 11078494.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2]
